Green Thumb Industries has submitted applications to the U.S. Drug Enforcement Administration (DEA) to register its state-licensed medical cannabis operations following the recent rescheduling of medical marijuana to Schedule III. This change is significant as it opens opportunities for more research, improved tax treatment, and federal normalization of the cannabis industry. Green Thumb operates over 110 retail locations across 14 U.S. markets and will discuss this milestone along with its Q1 2026 financial results on May 6. The DEA registration marks a key step toward a regulated federal cannabis market in the U.S.
Ouster's stock surged nearly 8% in premarket trading after expanding its manufacturing partnership with Benchmark Electronics to scale production of its new REV8 digital lidar sensors. The REV8 sensors target industrial, robotics, automotive, and sma...
Safehold Inc. announced a common stock dividend of $0.177 per share for the second quarter of 2026, representing an annualized rate of $0.708 per share. The dividend will be paid on July 15, 2026, to shareholders of record as of June 30, 2026. Safeho...
Wedbush analyst Dan Ives praised SpaceX's IPO as a 'Goldilocks outcome' that reassures investors and supports the tech sector. The successful debut, with shares closing 19.3% above the IPO price, signals strong investor interest and paves the way for...
The global demand for critical minerals, especially lithium, is rising sharply due to energy transition, electric vehicles, and advanced manufacturing needs. Supply is constrained by maturing deposits, export restrictions, and concentration in a few ...
IREN Limited has completed the acquisition of Nostrum Group, a Spanish developer of grid-connected AI data centers, marking IREN's entry into the European market. This acquisition adds approximately 490MW of secured power capacity in Spain and includ...
